Literature DB >> 19463745

Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.

Takuo Hirose1, Kazuhiro Takahashi, Nobuyoshi Mori, Takashi Nakayama, Masahiro Kikuya, Takayoshi Ohkubo, Masahiro Kohzuki, Kazuhito Totsune, Yutaka Imai.   

Abstract

Urotensin II (UII) and urotensin II-related peptide (URP) are novel vasoactive peptides that share urotensin II receptor (UT). We have recently reported that expressions of URP and UT were up-regulated in kidneys of rats with renal failure or hypertension. To clarify possible changes of the UII system expression in cardiovascular organs with hypertension, we examined the gene expression of UII, URP and UT in hearts and aortae of hypertensive rats. Furthermore, the expression was compared with that of endothelin-1 (ET-1). Quantitative reverse transcription polymerase chain reaction analysis showed that expression levels of UII mRNA and UT mRNA were significantly elevated in the atrium of 11-12-week-old spontaneously hypertensive rats (SHR) compared with age-matched Wistar-Kyoto rats (WKY). Moreover, UT mRNA expression was elevated in the ventricle of 11-12-week-old SHR. In the aorta, expression levels of URP mRNA and UT mRNA were significantly elevated in 11-12-week-old SHR compared with age-matched WKY, similarly to those in the kidney. In contrast, expression levels of ET-1 were significantly decreased in both the heart and the kidney of 11-12-week-old SHR compared with age-matched WKY. Immunohistochemistry showed that URP and UT were immunostained in cardiomyocytes, with weaker immunostaining in vascular endothelial and smooth muscle cells, in both SHR and WKY. These findings indicate that the gene expression of the UII system components (UII, URP and UT) and ET-1 is differently regulated in hypertension, and that the UII system in the heart and aortae may have certain pathophysiological roles in hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19463745     DOI: 10.1016/j.peptides.2009.02.009

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  9 in total

1.  Insights into the Molecular Determinants Involved in Urocontrin and Urocontrin A Action.

Authors:  Etienne Billard; David Chatenet
Journal:  ACS Med Chem Lett       Date:  2020-08-20       Impact factor: 4.345

2.  Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation.

Authors:  D Chatenet; M Létourneau; Q T Nguyen; N D Doan; J Dupuis; A Fournier
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

3.  Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells.

Authors:  Myriam Iglewski; Stephen R Grant
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

4.  A quantitative trait locus for ascites on chromosome 9 in broiler chicken lines.

Authors:  Sriram Krishnamoorthy; Candace D Smith; Adnan A Al-Rubaye; Gisela F Erf; Robert F Wideman; Nicholas B Anthony; Douglas D Rhoads
Journal:  Poult Sci       Date:  2014-02       Impact factor: 3.352

5.  Update on the urotensinergic system: new trends in receptor localization, activation, and drug design.

Authors:  David Chatenet; Thi-Tuyet M Nguyen; Myriam Létourneau; Alain Fournier
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-02       Impact factor: 5.555

Review 6.  The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.

Authors:  Hélène Castel; Laurence Desrues; Jane-Eileen Joubert; Marie-Christine Tonon; Laurent Prézeau; Marie Chabbert; Fabrice Morin; Pierrick Gandolfo
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-25       Impact factor: 5.555

7.  Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions.

Authors:  Turgay Ulas; Hakan Buyukhatipoglu; Mehmet S Dal; Idris Kirhan; Zekeriya Kaya; Mehmet E Demir; Irfan Tursun; Mehmet A Eren; Timucin Aydogan; Yusuf Sezen; Nurten Aksoy
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

8.  Autocrine Human Urotensin II Enhances Macrophage-Derived Foam Cell Formation in Transgenic Rabbits.

Authors:  Sihai Zhao; Yafeng Li; Shoucui Gao; Xiaojing Wang; Lijing Sun; Daxing Cheng; Liang Bai; Hua Guan; Rong Wang; Jianglin Fan; Enqi Liu
Journal:  Biomed Res Int       Date:  2015-11-12       Impact factor: 3.411

9.  Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma.

Authors:  Vadim Le Joncour; Pierre-Olivier Guichet; Kleouforo-Paul Dembélé; Alexandre Mutel; Daniele Campisi; Nicolas Perzo; Laurence Desrues; Romain Modzelewski; Pierre-Olivier Couraud; Jérôme Honnorat; François-Xavier Ferracci; Florent Marguet; Annie Laquerrière; Pierre Vera; Pierre Bohn; Olivier Langlois; Fabrice Morin; Pierrick Gandolfo; Hélène Castel
Journal:  Front Cell Dev Biol       Date:  2021-04-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.